- Latest available (Revised) - English
- Latest available (Revised) - Welsh
- Original (As made) - English
- Original (As made) - Welsh
The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020
You are here:
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Changes to legislation:
The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020, PART 4 is up to date with all changes known to be in force on or before 01 February 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Changes and effects yet to be applied to Schedule 2 Part 4:
- Sch. 5 para. 5A inserted by S.I. 2024/1196 reg. 3(3)
- Sch. 5 para. 23(6A) inserted by S.I. 2024/1196 reg. 3(15)
- Sch. 5 para. 23(6B) inserted by S.I. 2024/1196 reg. 3(16)
- Sch. 5 para. 28(3)(c)(iiia) inserted by S.I. 2024/1196 reg. 3(20)
Changes and effects yet to be applied to the whole Instrument associated Parts and Chapters:
Whole provisions yet to be inserted into this Instrument (including any effects on those provisions):
- Sch. 5 para. 5A inserted by S.I. 2024/1196 reg. 3(3)
- Sch. 5 para. 23(6A) inserted by S.I. 2024/1196 reg. 3(15)
- Sch. 5 para. 23(6B) inserted by S.I. 2024/1196 reg. 3(16)
- Sch. 5 para. 28(3)(c)(iiia) inserted by S.I. 2024/1196 reg. 3(20)
PART 4E+WApplications for outline consent and premises approval
Details of the applicationE+W
32. Name of the Local Health Board to which the application is made.
Commencement Information
I1Sch. 2 para. 32 in force at 1.10.2020, see reg. 1(2)(b)
33. Type of application (outline consent, premises approval or both).E+W
Commencement Information
I2Sch. 2 para. 33 in force at 1.10.2020, see reg. 1(2)(b)
Details of the applicantE+W
34. Name and address of the applicant.
Commencement Information
I3Sch. 2 para. 34 in force at 1.10.2020, see reg. 1(2)(b)
35. The General Medical Council reference number under which the applicant is included in the List of Registered Medical Practitioners maintained by the General Medical Council.E+W
Commencement Information
I4Sch. 2 para. 35 in force at 1.10.2020, see reg. 1(2)(b)
Application for outline consentE+W
36. Description and map of the area within which the applicant wishes to provide pharmaceutical services.
Commencement Information
I5Sch. 2 para. 36 in force at 1.10.2020, see reg. 1(2)(b)
37. Address of any pharmacy within the area described and delineated under paragraph 36.E+W
Commencement Information
I6Sch. 2 para. 37 in force at 1.10.2020, see reg. 1(2)(b)
Application for premises approvalE+W
38. The address of the practice premises from which the applicant applies to provide pharmaceutical services and whether those practice premises are listed premises in relation to a different area.
Commencement Information
I7Sch. 2 para. 38 in force at 1.10.2020, see reg. 1(2)(b)
39. Distance between those premises and the nearest pharmacy (and the address of that pharmacy).E+W
Commencement Information
I8Sch. 2 para. 39 in force at 1.10.2020, see reg. 1(2)(b)
40. Whether the application is for premises approval for additional premises or to relocate to new premises (and if the latter the distance from the new premises to the premises in respect of which the applicant currently has premises approval).E+W
Commencement Information
I9Sch. 2 para. 40 in force at 1.10.2020, see reg. 1(2)(b)
41. Whether the application arises because a practice amalgamation has taken place or will be taking place and, if so, the names of the doctors or contractors participating in the amalgamation.E+W
Commencement Information
I10Sch. 2 para. 41 in force at 1.10.2020, see reg. 1(2)(b)
42. If outline consent has already been granted a description and map of the area in respect of which consent has been granted.E+W
Commencement Information
I11Sch. 2 para. 42 in force at 1.10.2020, see reg. 1(2)(b)
43. Details of any other medical practice premises which have been granted premises approval or in respect of which an application has already been made but not yet determined by the Local Health Board.E+W
Commencement Information
I12Sch. 2 para. 43 in force at 1.10.2020, see reg. 1(2)(b)
Pharmaceutical services to be providedE+W
44. The pharmaceutical services to be provided and the opening hours and days on which those services will be provided.
Commencement Information
I13Sch. 2 para. 44 in force at 1.10.2020, see reg. 1(2)(b)
Prejudice testE+W
45. The reasons why the applicant considers that granting the application will not prejudice the proper provision of primary medical services, dispensing services or pharmaceutical services in the controlled locality in which the premises specified in the application are situated.
Commencement Information
I14Sch. 2 para. 45 in force at 1.10.2020, see reg. 1(2)(b)
Meeting identified needsE+W
46. The reasons why the applicant considers it is necessary to grant the application in order to meet a need identified in a relevant pharmaceutical needs assessment.
Commencement Information
I15Sch. 2 para. 46 in force at 1.10.2020, see reg. 1(2)(b)
Applicant’s undertakingE+W
47. The applicant must give an undertaking that if the application is granted and outline consent and premises approval is in effect the applicant will provide the pharmaceutical services from the practice premises in respect of which the application is granted in accordance with the terms of service.
Commencement Information
I16Sch. 2 para. 47 in force at 1.10.2020, see reg. 1(2)(b)
Options/Help
Print Options
PrintThe Whole Instrument
PrintThe Whole Schedule
PrintThis Part only
You have chosen to open The Whole Instrument
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
You have chosen to open The Whole Instrument as a PDF
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
You have chosen to open the Whole Instrument
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area. The revised version is currently only available in English.
Original (As Enacted or Made) - English: The original English language version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Original (As Enacted or Made) - Welsh:The original Welsh language version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.